TREM2 and early-onset autosomal dominant Alzheimer disease: TREM2 mutations strongly increase the risk of developing Alzheimer’s disease (AD) [7, 8] and other neurodegenerative diseases including frontotemporal dementia (FTD), Parkinson’s disease and amyotrophic lateral sclerosis [9–12].